Showing 1 - 20 results of 18,701 for search '(( significant ((size decrease) OR (sizes decrease)) ) OR ( significant cause decreased ))', query time: 0.88s Refine Results
  1. 1
  2. 2

    Encapsulation efficiency significantly decreases with increasing starting bacterial concentration. by Kelly C. Freudenberger Catanzaro (6701789)

    Published 2022
    “…Significant differences between starting bacterial concentrations within nozzle sizes are shown as: *: <i>p</i> < 0.05.…”
  3. 3

    Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods. by Amrita Banerjee (382658)

    Published 2021
    “…<p>Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods.…”
  4. 4

    <i>Trappc9</i> deficient mice show a decrease in brain weight and size. by Zhengzheng S. Liang (9333660)

    Published 2020
    “…<p><b>(A)</b><i>Trappc9</i> deficient mice show a decrease in brain weight in a parent-of-origin manner. …”
  5. 5
  6. 6
  7. 7
  8. 8

    Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

    Published 2023
    “…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”
  9. 9

    Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

    Published 2021
    “…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”
  10. 10

    Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”
  11. 11

    Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”
  12. 12

    Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”
  13. 13
  14. 14
  15. 15

    Data_Sheet_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”
  16. 16

    Data_Sheet_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”
  17. 17
  18. 18

    Overexpression of Gαq decreases cell number and cell size. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    “…Overexpression of Gαq in the pouch results in a decrease in total wing area, cell number and cell size. 10 samples were analyzed per condition. …”
  19. 19
  20. 20